Mirati Ther

Company Profile

Mirati Ther had its IPO on 2004-06-29 under the ticker symbol MRTX.

The company operates in the Healthcare sector and Biotechnology industry. Mirati Ther has a staff strength of 587 employees.

Stock update

Shares of Mirati Ther opened at $35.12 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $34.24 - $35.39, and closed at $35.13.

This is a +0.03% increase from the previous day's closing price.

A total volume of 932,549 shares were traded at the close of the day’s session.

In the last one week, shares of Mirati Ther have slipped by -6.94%.

Mirati Ther's Key Ratios

Mirati Ther has a market cap of $2.45 billion, indicating a price to book ratio of 2.1294 and a price to sales ratio of 207.5881.

In the last 12-months Mirati Ther’s revenue was $27.22 million with a gross profit of $-519791000 and an EBITDA of $-775470016. The EBITDA ratio measures Mirati Ther's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Mirati Ther’s operating margin was -2862.61% while its return on assets stood at -44.38% with a return of equity of -80.13%.

In Q2, Mirati Ther’s quarterly earnings growth was a positive 0% while revenue growth was a positive 155.3%.

Mirati Ther’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-12.65 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mirati Ther’s profitability.

Mirati Ther stock is trading at a EV to sales ratio of 106.3062 and a EV to EBITDA ratio of -1.69. Its price to sales ratio in the trailing 12-months stood at 207.5881.

Mirati Ther stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$915.04 million

Total Liabilities

$139.99 million

Operating Cash Flow

$15.53 million

Capital Expenditure

$722000

Dividend Payout Ratio

0%

Mirati Ther ended 2024 with $915.04 million in total assets and $0 in total liabilities. Its intangible assets were valued at $915.04 million while shareholder equity stood at $728.95 million.

Mirati Ther ended 2024 with $0 in deferred long-term liabilities, $139.99 million in other current liabilities, 58000.00 in common stock, $-2814388000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $129.87 million and cash and short-term investments were $779.43 million. The company’s total short-term debt was $7,961,000 while long-term debt stood at $0.

Mirati Ther’s total current assets stands at $818.92 million while long-term investments were $4.57 million and short-term investments were $649.57 million. Its net receivables were $15.70 million compared to accounts payable of $32.51 million and inventory worth $8.64 million.

In 2024, Mirati Ther's operating cash flow was $15.53 million while its capital expenditure stood at $722000.

Comparatively, Mirati Ther paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$35.13

52-Week High

$101.3

52-Week Low

$27.3

Analyst Target Price

$54

Mirati Ther stock is currently trading at $35.13 per share. It touched a 52-week high of $101.3 and a 52-week low of $101.3. Analysts tracking the stock have a 12-month average target price of $54.

Its 50-day moving average was $35.26 and 200-day moving average was $43.29 The short ratio stood at 6.06 indicating a short percent outstanding of 0%.

Around 689.1% of the company’s stock are held by insiders while 11241.2% are held by institutions.